Nutritional, Metabolic, Endocrine Pregnancy and Childbirth Iron deficiency anemia in pregnancy
Conditions
Interventions
Lactoferrin
Ferrous sulphate
Sponsors
Faculty of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Pregnant women with single fetus, in the second trimester, with iron deficiency anemia (hemoglobin level <11 g/dL and ferritin levels <25 ng/dL)
Exclusion criteria
Exclusion criteria: Women with a history of anemia due to any other causes such as chronic blood loss, hemolytic anemia, and thalassemia (including thalassemic trait), severe anemia requiring blood transfusion, bronchial asthma, clinical and/or laboratory evidence of hepatic, renal, hematologic or cardiovascular abnormalities, history of peptic ulcer, hypersensitivity to iron preparations and treatment with any other iron preparation in the last one month before study entry and suspected acute infection were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy parameter was the amount of increase in Hemoglobin concentration by 4 and 8 weeks, the adverse effects (the patients were asked to report any unusual or unpleasant symptoms during the study period) related to iron therapy and the patient compliance to treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Obstetric outcome in terms of gestational age at delivery, mode of delivery, maternal complications (postpartum hemorrhage and defective lactation) and neonatal outcome (neonatal weight, admission to neonatal intensive care unit and neonatal death defined as death in the first four weeks after birth) were assessed as a secondary outcome. | — |
Countries
Egypt
Contacts
Public ContactHala Marawan
Lecturer in Community medicine and Public health
Outcome results
None listed